| Filter Options | ||||||
|---|---|---|---|---|---|---|
|
Public title |
Verify status |
Pay status |
||||
|
Study ailment |
Study type |
Study phase |
||||
|
Applicant |
Study leader |
Primary sponsor |
||||
|
Countries of recruitment and research settings |
|
|||||
| More Options | ||||||
| Reg No. in ChiCTR | Public title | Ailment | Type | Phase | Registration time | Viewed | Operation |
|---|---|---|---|---|---|---|---|
| NCT07625722 |
Effect of Thyroxine Supplement on 2-year Neurologic Development in Small for Gestational Age Infants Shandong Provincial Hospital Affiliated to Shandong First Medical University |
|
Therapy Study |
Post-market |
2026-11-06 | 3 | Patient list |
| ChiCTR2600133307 |
Foshan Shunde Integrated Traditional Chinese and Western Medicine Hospital (Jun'an Hospital) |
Major Adverse Cardiovascular Events |
|
|
2026-11-06 | 14 | Patient list |
| 暂无 |
|
|
Therapy Study |
Post-market |
2026-11-04 | 51 | Patient list |
| ChiCTR2600135466 |
Changes in Gut Microbiota and Metabolites in Relation to Acute Noise Exposure the First Affiliated Hospital of Air Force Medical University |
|
Therapy Study |
Premarket |
2026-10-29 | 118 | Patient list |
| ChiCTR2600131913 |
|
|
|
|
2026-10-27 | 96 | Patient list |
| NCT07321197 |
Tianjin Medical University Second Hospital |
Renal cell carcinoma |
Therapy Study |
Premarket |
2026-10-26 | 113 | Patient list |
| ChiCTR2600123852 |
Shunde Hospital Guangzhou University of Chinese Medicine (ShunDe District Hospital of Chinese Medicine of Foshan City) |
Lumbar degenerative disease, opioid-related adverse effects |
Therapy Study |
|
2026-10-26 | 121 | Patient list |
| MR-11-26-084769 |
|
|
|
|
2026-10-24 | 113 | Patient list |
| ChiCTR2600127535 |
|
|
|
|
2026-10-21 | 129 | Patient list |
| 无 |
|
无 |
Prognostic Study |
Premarket |
2026-10-20 | 110 | Patient list |